Organogenesis Holdings Inc.ORGONASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank89
3Y CAGR+15.3%
5Y CAGR+4.5%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+15.3%/yr
Annual compound
5Y CAGR
+4.5%/yr
Recent acceleration
Percentile
P89
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 13.72% | +319.5% |
| 2024 | 3.27% | -60.7% |
| 2023 | 8.32% | -7.0% |
| 2022 | 8.94% | -52.0% |
| 2021 | 18.61% | +69.2% |
| 2020 | 11.00% | +245.5% |
| 2019 | -7.56% | +68.8% |
| 2018 | -24.25% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |